[Hengrui Medicine: Repurchased 335,000 company A shares for the first time] On September 17, Hengrui Medicine (600276.SH) announced that the company will conduct centralized bidding transactions on September 17, 2026. For the first time, 335,000 A shares were repurchased, accounting for 0.005% of the company's total share capital. The highest transaction price was 43.58 yuan/share and the lowest price was 43.10 yuan/share. The total amount paid was 14.5036 million yuan. According to the previous plan, the company plans to use its own funds to repurchase shares for the employee stock ownership plan through centralized bidding. The total repurchase funds shall not be less than 1 billion yuan and not exceed 2 billion yuan. The repurchase period is from August 19, 2026 to August 18, 2027.